Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-05

FDA Approved: CHOLESTYRAMINE — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approves Micro Labs Limited's original application for CHOLESTYRAMINE, a generic bile acid sequestrant used to lower cholesterol in patients with hyperlipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholestyramine (cholestyramine)

Snippet

ORIG AP for CHOLESTYRAMINE (CHOLESTYRAMINE)